Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT00007527
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2000-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
Sponsor:
US Department of Veterans Affairs
Organization:
Organization Data
Organization:
Class:
FED
Study ID:
1018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
FED
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None